Home Phase 3 Trial Huons Completes Phase 3 Trials for Hutox

Huons Completes Phase 3 Trials for Hutox

255
0

Huons Global completed phase 3 clinical trials for Hutox, its botulinum (BTX) strain. Based in South Korea, the company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system as well as other focus areas.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.